PCC Rokita (WAR:PCR) Other Stockholders Equity: zł-13 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:PCR PCC Rokita SA WAR:PCR
82 GF Score
Price zł69.50
GF Value zł66.24
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is PCC Rokita Other Stockholders Equity?

PCC Rokita WAR:PCR +8.26% 82 Other Stockholders Equity is zł-13 Mil as of Mar. 2026. GuruFocus rates WAR:PCR with a GF Score™ of 82/100 and a GF Value™ of zł66.24 (Fairly Valued). The stock has 8 warning signs investors should review.

PCC Rokita's Other Stockholders Equity for the quarter that ended in Mar. 2026 was zł-13 Mil.

PCC Rokita's quarterly Other Stockholders Equity increased from Sep. 2025 (zł-14 Mil) to Dec. 2025 (zł-14 Mil) and increased from Dec. 2025 (zł-14 Mil) to Mar. 2026 (zł-13 Mil).

PCC Rokita's annual Other Stockholders Equity increased from Dec. 2023 (zł-15 Mil) to Dec. 2024 (zł-14 Mil) and increased from Dec. 2024 (zł-14 Mil) to Dec. 2025 (zł-14 Mil).

PCC Rokita Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for PCC Rokita's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PCC Rokita Other Stockholders Equity Chart

PCC Rokita Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -13.56 -13.25 -14.58 -13.81 -13.54

PCC Rokita Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.39 -14.20 -13.95 -13.54 -13.39
WAR:PCR
82GF Score
PCC Rokita SA WAR:PCR
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PCC Rokita Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of zł-13 Mil mean?
PCC Rokita (WAR:PCR) has a Other Stockholders Equity of zł-13 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on PCC Rokita and its competitors.
Is PCC Rokita's Other Stockholders Equity too high?
PCC Rokita's current Other Stockholders Equity is zł-13 Mil. Overall, PCC Rokita has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PCC Rokita's Other Stockholders Equity compare to DOW?
PCC Rokita's Other Stockholders Equity of zł-13 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Chemicals company?
A good Other Stockholders Equity depends on the Chemicals industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on PCC Rokita and its competitors. PCC Rokita's current Other Stockholders Equity is zł-13 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PCC Rokita stock overvalued right now?
Based on GuruFocus' analysis, PCC Rokita (WAR:PCR) is currently considered Fairly Valued. The stock's GF Value™ is zł66.24, compared to a current price of zł69.50 — trading 4.9% above its estimated fair value. The current Other Stockholders Equity is zł-13 Mil. PCC Rokita's overall GF Score™ is 82/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For PCC Rokita (WAR:PCR), the current Other Stockholders Equity is zł-13 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PCC Rokita (WAR:PCR) Overvalued in 2026?

Based on GuruFocus' analysis, PCC Rokita stock appears to be overvalued. The current stock price of zł69.50 is trading 4.9% above its estimated GF Value™ of zł66.24. GuruFocus considers PCC Rokita to be Fairly Valued.

Key valuation signals for WAR:PCR:

  • Other Stockholders Equity: zł-13 Mil
  • GF Value™: zł66.24 vs. price of zł69.50 (4.9% above fair value)
  • GF Score™: 82/100 with 8 warning signs

No single metric tells the full story. See the WAR:PCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PCC Rokita Business Description

Other Exchanges 229:Germany
Address ul. Sienkiewicza 4, Brzeg Dolny, POL, 56-120
PCC Rokita SA is engaged in manufacturing chemicals. Its products include Polyols, Chloralkali, Chlorobenzene, Phosphorus derivatives, and Naphthalene derivatives. It serves adhesives, agrochemicals, building and construction, case, detergents, fire prevention, food and fuel industry, furniture, I&I cleaning, lubricants and functional fluids, metallurgical, mining and drilling, oilfield, paints and coatings, personal care, pharmaceuticals, plastics, power, printing ink, pulp and paper, raw materials and intermediates, refrigeration and household appliances, sports and recreation, tanning and textile, transportation, and water and wastewater treatment industries.
82GF Score

Get the complete analysis for WAR:PCR

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł69.50
Price
zł66.24
GF Value